Integrated BioPharma (INBP) Stock Price, News & Analysis

Company Overview

Integrated BioPharma, Inc., together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. The Other Nutraceutical Businesses segment distributes healthful nutritional products for sale through mass market, grocery, drug, and vitamin retailers under the Peaceful Sleep and Wheatgrass brands, as well as other branded proprietary nutraceutical products. This segment also sells private label vitamin and nutritional supplement products through the Internet; provides warehousing and fulfilment services; and distributes fine natural botanicals, including multi minerals, as well as raw materials. The company was formerly known as Integrated Health Technologies, Inc. Integrated BioPharma, Inc. was incorporated in 1980 and is based in Hillside, New Jersey.

Key Stats

• Today's Range: $0.18 to $0.18
• 50-Day Range: $0.15 to $0.19
• 52-Week Range: $0.14 to $0.42
• Volume: 10,000 shs
• Average Volume: 10,540 shs
• Market Capitalization: $5.58 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Last Earnings: 5/08/2026
• Today: 9/01/2026
• Fiscal Year End: 6/30/2027

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:INBP
• CIK: 1016504
• Web: www.integratedbiopharma.com
• Phone: (973) 926-0816
• Fax: 973-926-1735
• Employees: 150
• Year Founded: 1995

Profitability

• EPS (Trailing Twelve Months): ($0.07)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $810 thousand
• Net Margins: -3.43%
• Pretax Margin: -2.32%
• Return on Equity: -8.32%
• Return on Assets: -6.57%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 3.25
• Quick Ratio: 1.78

Sales & Book Value

• Annual Sales: $54.35 million
• Price / Sales: 0.10
• Cash Flow: $0.07 per share
• Price / Cash Flow: 2.68
• Book Value: $0.66 per share
• Price / Book: 0.27

Miscellaneous

• Outstanding Shares: 30,980,000
• Free Float: 10,098,000
• Market Cap: $5.58 million
• Optionable: Not Optionable
• Beta: 0.36